Crinetics Pharmaceuticals (CRNX) Interest & Investment Income (2017 - 2025)
Historic Interest & Investment Income for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to $12.5 million.
- Crinetics Pharmaceuticals' Interest & Investment Income rose 1397.42% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.2 million, marking a year-over-year increase of 6336.97%. This contributed to the annual value of $41.4 million for FY2024, which is 20838.79% up from last year.
- Latest data reveals that Crinetics Pharmaceuticals reported Interest & Investment Income of $12.5 million as of Q3 2025, which was up 1397.42% from $13.5 million recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' Interest & Investment Income registered a high of $14.8 million during Q1 2025, and its lowest value of $24000.0 during Q3 2021.
- In the last 5 years, Crinetics Pharmaceuticals' Interest & Investment Income had a median value of $2.3 million in 2023 and averaged $5.6 million.
- In the last 5 years, Crinetics Pharmaceuticals' Interest & Investment Income plummeted by 9460.43% in 2021 and then skyrocketed by 615000.0% in 2022.
- Crinetics Pharmaceuticals' Interest & Investment Income (Quarter) stood at $80000.0 in 2021, then skyrocketed by 2280.0% to $1.9 million in 2022, then surged by 253.05% to $6.7 million in 2023, then soared by 113.75% to $14.4 million in 2024, then decreased by 12.69% to $12.5 million in 2025.
- Its Interest & Investment Income stands at $12.5 million for Q3 2025, versus $13.5 million for Q2 2025 and $14.8 million for Q1 2025.